Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,347,254
-$95,659,378 QoQ
Shares Held
343,100
-72.6% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
2.32%
of 13F equity value
Holder Rank
#232
of 2,275 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $93,878,265 across 2 Drug Manufacturers - General names. GILD ranks #2 (46.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
876,970 | $50,531,011 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
343,100 | $43,347,254 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,347,254 | 343,100 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $139,006,632 | 1,252,312 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $116,447,647 | 1,050,308 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,937,745 | 418,900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $71,515,347 | 774,227 | Shares | Sole | 2025-02-14 | |
| 2022-09-30 | $29,759,256 | 482,400 | Shares | Sole | 2022-11-08 | |
| 2020-06-30 | $31,044,826 | 403,494 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||